CSIMarket
 

Prophase Labs Inc   (PRPH)
Other Ticker:  
 

Prophase Labs Inc 's Working Capital Per Sales

PRPH's Working Capital and Revenue growth



PRPH Working Capital Per Revenue (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Working Capital Change -37.75 % -23.79 % -19.89 % -3.66 % 54.8 %
Y / Y Revenue Change -65.59 % -57.21 % -59.39 % -51.67 % 155.49 %
Working Capital Per Revenue 0.66 0.59 0.52 0.42 0.36
Total Ranking # 2417 # 1835 # 1718 # 18 # 1251
Seq. Working Capital Change -19.14 % -3.55 % -4.35 % -16.55 % -1.01 %
Seq. Revenue Change -33.11 % -35.51 % -11.55 % -9.82 % -16.82 %





Comment on PRPH's Working Capital Per Revenue in the third quarter 2023
Prophase Labs Inc 's Working Capital Per Revenue sequentially grew to 0.66 during the Q3 2023, below the Prophase Labs Inc average. Due to increase of revenue in the Q3 2023 year on year by -65.59%.

Within Healthcare sector 75 other companies have achieved lower Working Capital Per Revenue during the Q3 2023. While Working Capital Per Revenue total ranking has deteriorated in the third quarter 2023, compared to previous quarter from 1835 to 2417.
Working Capital Per Revenue Ranking
Within: No.
Industry # 28
Sector # 76
S&P 500 # 2417


Working Capital Per Revenue Statistics
High Average Low
3.48
0.82
0.18
(Dec 31 2017)   (Dec 31 2016)



Financial Statements
Prophase Labs Inc 's Working Capital $ 33 Millions Visit PRPH's Balance sheet
Prophase Labs Inc 's Revenues $ 8 Millions Visit PRPH's Income Statement
Where are PRPH's Sales coming from? Visit PRPH's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Sep 30 2023, within Healthcare Sector Working Capital Per Revenue
Evoke Pharma Inc   1.79 
Macrogenics Inc   1.79 
Sarepta Therapeutics Inc   1.78 
Inmed Pharmaceuticals Inc   1.77 
Oncocyte Corporation  1.76 
Fulgent Genetics Inc   1.74 
2seventy Bio Inc   1.73 
Arrowhead Pharmaceuticals Inc   1.72 
Sensus Healthcare Inc   1.72 
The Beauty Health Company  1.69 
Ligand Pharmaceuticals Incorporated  1.69 
Clearpoint Neuro Inc   1.69 
Karyopharm Therapeutics Inc   1.67 
Twist Bioscience Corporation  1.63 
Eargo Inc   1.61 
Amarin Corp Plcuk  1.57 
Point Biopharma Global Inc   1.55 
Mirum Pharmaceuticals Inc   1.53 
Ocular Therapeutix Inc   1.52 
Avita Medical Inc   1.51 
G1 Therapeutics Inc   1.49 
Biomerica Inc   1.48 
Intra cellular Therapies Inc   1.48 
Reflect Scientific Inc   1.48 
Beigene ltd   1.47 
Retractable Technologies inc   1.45 
Marker Therapeutics inc   1.39 
Nuwellis Inc   1.37 
Standard Biotools Inc   1.36 
Revance Therapeutics Inc   1.35 
Date modified: 2023-11-14T22:45:30+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com